Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Population Screening Market Expected To Become By 2029 Compared With Its 2025 Level?
The population screening market has observed strong expansion over recent years. It is anticipated to increase from $29.31 billion in 2024 to $31.39 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.1%. The historical growth of this market can be linked to disease prevention initiatives, government health policies, increasing healthcare costs, and greater disease awareness.
The population screening market is projected to experience robust expansion over the coming years. It is forecast to reach $41.4 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.2%. The anticipated growth during this period can be attributed to the transition towards personalized medicine, the increasing elderly population and prevalence of chronic diseases, the integration of artificial intelligence and data analytics, and the broader availability of screening. Key developments expected in the forecast period include advancements in medical technology, the expansion of genomics and precision screening, the adoption of telehealth and remote screening, the emergence of multi-disease screening panels, and a focus on health equity and accessibility.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp
Which Major Market Drivers Are Shaping The Future Of The Population Screening Market?
The increasing occurrence of cancer is projected to stimulate the expansion of the population screening market in the future. Cancer is defined as a disease where certain cells within the body grow abnormally and disseminate to various other regions of the human system. Early detection of cancer through population screening can lead to more effective treatment options and improved patient outcomes. For example, reports released by the American Cancer Society Inc., a US-based voluntary health organization, in January 2023, indicated 608,570 cancer deaths in 2022 and an estimated 1.9 million new cancer cases, contrasting with 606,520 cancer deaths recorded in 2021. Consequently, the growing incidence of cancer is propelling the development of the population screening market.
Which Key Segments Fueling The Population Screening Market?
The population screeningmarket covered in this report is segmented –
1) By Product: Hardware Equipment; Testing Or Lab; Analytics Or Interpretation
2) By Gender: Male; Female
3) By Age: Ages Less Than 15; 15-65; Ages 65 And Above
4) By Business: Hospitals; Research Institutes; Diagnostic Labs
Subsegments:
1) By Hardware Equipment: Diagnostic Devices; Sample Collection Devices; Imaging Equipment
2) By Testing Or Lab: Laboratory Testing Kits; Point-Of-Care Testing; Blood And Urine Testing Services
3) By Analytics Or Interpretation: Software Solutions For Data Analysis; Interpretation Services; Reporting Tools
What Are The Latest Industry Trends Transforming The Population Screening Market?
Leading companies in the population screening market are developing advanced services, such as newborn mass screening, to improve early detection and enhance health outcomes for infants. Newborn mass screening is a public health program where newborns are examined shortly after birth for various genetic, metabolic, hormonal, and functional disorders that may not be obvious at birth but can lead to severe health issues if left untreated. For instance, in May 2024, Shimadzu Techno-Research Inc., a contract analysis company and subsidiary of Shimadzu Corporation, a Japan-based manufacturer of precision instruments, introduced a new contract service offering polymerase chain reaction (PCR) testing for expanded newborn mass screening. This service will screen for combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), which, while currently impacting a small percentage of newborns, demand immediate intervention upon diagnosis.
Which Major Industry Participants Are Leading The Population Screening Market Growth?
Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report
Which Region Currently Holds The Largest Share Of The Population Screening Market?
North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Population Screening Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12587&type=smp
Browse Through More Reports Similar to the Global Population Screening Market 2025, By The Business Research Company
Population Health Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/population-health-management-global-market-report
Lung Cancer Diagnostic And Screening Global Market Report 2025
Cellular Health Screening Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
